STAT+: A bipartisan group of lawmakers urges the FDA to close a peptide loophole
A bipartisan group of lawmakers is urging the FDA to plug a loophole used to import knockoff retatrutide, an investigational obesity drug made by Eli Lilly.
A bipartisan coalition of legislators has written to the FDA, urging the agency to eliminate a regulatory loophole that permits certain peptides to be tested without being evaluated on the specific patient groups they are intended for. The lawmakers argue that this exemption allows untested drugs to reach the market prematurely, potentially putting patients at risk.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
